NCT00492076View on ClinicalTrials.gov

Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Allergic Asthma
Interventions
BIOLOGICAL

Pangramin Plus D. pteronyssinus 100%

"1. Active. Pangramin Plus D. pteronyssinus 100%~2. Placebo. Pangramin Plus placebo"

Trial Locations (1)

31002

Hospital Virgen del Camino, Allergology Service, Pamplona

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT00492076 - Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma | Biotech Hunter | Biotech Hunter